Jörg Westermann

2.8k total citations
85 papers, 1.2k citations indexed

About

Jörg Westermann is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Jörg Westermann has authored 85 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hematology, 35 papers in Immunology and 34 papers in Oncology. Recurrent topics in Jörg Westermann's work include Acute Myeloid Leukemia Research (25 papers), Immunotherapy and Immune Responses (22 papers) and CAR-T cell therapy research (17 papers). Jörg Westermann is often cited by papers focused on Acute Myeloid Leukemia Research (25 papers), Immunotherapy and Immune Responses (22 papers) and CAR-T cell therapy research (17 papers). Jörg Westermann collaborates with scholars based in Germany, United States and Switzerland. Jörg Westermann's co-authors include Bernd Dörken, Antonio Pezzutto, Anne Flörcken, Martin Lipp, Uta E. Höpken, Thomas Burmeister, Nina Rosa Neuendorff, Joachim Kopp, Lars Bullinger and Philipp le Coutre and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Jörg Westermann

79 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jörg Westermann Germany 21 611 476 340 338 193 85 1.2k
Il‐Kang Na Germany 22 594 1.0× 437 0.9× 520 1.5× 374 1.1× 275 1.4× 69 1.4k
Janet Ayello United States 21 529 0.9× 705 1.5× 341 1.0× 368 1.1× 167 0.9× 117 1.3k
Paulo Vidal Campregher Brazil 12 950 1.6× 569 1.2× 429 1.3× 323 1.0× 188 1.0× 57 1.7k
Takahiro Shima Japan 14 643 1.1× 491 1.0× 650 1.9× 541 1.6× 271 1.4× 59 1.5k
Mark Klinger United States 18 872 1.4× 696 1.5× 274 0.8× 504 1.5× 127 0.7× 30 1.7k
HE Heslop United States 18 592 1.0× 460 1.0× 485 1.4× 313 0.9× 226 1.2× 32 1.4k
Jean‐Jacques Sotto France 17 366 0.6× 410 0.9× 464 1.4× 406 1.2× 190 1.0× 42 1.1k
Friederike Kreisel United States 18 362 0.6× 384 0.8× 301 0.9× 337 1.0× 206 1.1× 61 1.4k
H Mizoguchi Japan 17 602 1.0× 506 1.1× 353 1.0× 345 1.0× 177 0.9× 54 1.4k
Mark W. Brunvand United States 15 554 0.9× 293 0.6× 126 0.4× 375 1.1× 112 0.6× 22 1.2k

Countries citing papers authored by Jörg Westermann

Since Specialization
Citations

This map shows the geographic impact of Jörg Westermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörg Westermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörg Westermann more than expected).

Fields of papers citing papers by Jörg Westermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jörg Westermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörg Westermann. The network helps show where Jörg Westermann may publish in the future.

Co-authorship network of co-authors of Jörg Westermann

This figure shows the co-authorship network connecting the top 25 collaborators of Jörg Westermann. A scholar is included among the top collaborators of Jörg Westermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jörg Westermann. Jörg Westermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wittenbecher, Friedrich, Jörg Westermann, Peter Thuss‐Patience, et al.. (2024). Effective symptom relief through continuous integration of palliative care in advanced renal cell carcinoma patients: comprehensive measurement using the palliative care base assessment. Palliative Care and Social Practice. 18. 396558216–396558216.
2.
Höhn, Oliver, et al.. (2022). Gene Gun Her2/neu DNA Vaccination: Evaluation of Vaccine Efficacy in a Syngeneic Her2/neu Mouse Tumor Model. Methods in molecular biology. 2521. 129–154. 6 indexed citations
3.
Meintker, Lisa, Alexander Höllein, F. Elsner, et al.. (2021). Knowledge transfer to enhance the performance of deep learning models for automated classification of B cell neoplasms. Patterns. 2(10). 100351–100351. 18 indexed citations
4.
Ostendorf, Benjamin N., et al.. (2018). Phenotypic characterization of aberrant stem and progenitor cell populations in myelodysplastic syndromes. PLoS ONE. 13(5). e0197823–e0197823. 19 indexed citations
5.
Schönlein, Martin, J. Henry M. Däbritz, Dorothy Ngo-Yin Fan, et al.. (2017). Therapy‐Induced Senescence Is a Predictor of Treatment Outcome in Acute Myeloid Leukemia. Blood. 130. 1393–1393. 2 indexed citations
6.
Westermann, Jörg, et al.. (2017). The splenic marginal zone shapes the phenotype of leukemia B cells and facilitates their niche-specific retention and survival. OncoImmunology. 6(6). e1323155–e1323155. 8 indexed citations
7.
Dörken, Bernd, et al.. (2016). CCL4 as an adjuvant for DNA vaccination in a Her2/neu mouse tumor model. Cancer Gene Therapy. 23(6). 162–167. 18 indexed citations
8.
Grau, Michael, Kerstin Gerlach, Ralph Kettritz, et al.. (2016). Splenic Marginal Zone Granulocytes Acquire an Accentuated Neutrophil B-Cell Helper Phenotype in Chronic Lymphocytic Leukemia. Cancer Research. 76(18). 5253–5265. 31 indexed citations
9.
Neuendorff, Nina Rosa, Thomas Burmeister, Bernd Dörken, & Jörg Westermann. (2016). BCR-ABL-positive acute myeloid leukemia: a new entity? Analysis of clinical and molecular features. Annals of Hematology. 95(8). 1211–1221. 52 indexed citations
10.
Oden, Felix, Stephen F. Marino, Jörg Westermann, et al.. (2015). Potent anti‐tumor response by targeting B cell maturation antigen (BCMA) in a mouse model of multiple myeloma. Molecular Oncology. 9(7). 1348–1358. 24 indexed citations
11.
Grau, Michael, Ioannis Anagnostopoulos, Kerstin Gerlach, et al.. (2014). Access to Follicular Dendritic Cells Is a Pivotal Step in Murine Chronic Lymphocytic Leukemia B-cell Activation and Proliferation. Cancer Discovery. 4(12). 1448–1465. 56 indexed citations
12.
Höhn, Oliver, Duc Vu, Gerd Baldenhofer, et al.. (2012). CCL19 as an adjuvant for intradermal gene gun immunization in a Her2/neu mouse tumor model: improved vaccine efficacy and a role for B cells as APC. Cancer Gene Therapy. 19(12). 880–887. 26 indexed citations
13.
Baldenhofer, Gerd, Shakeel Ahmed, Duc Vu, et al.. (2011). CCL21 (SLC) improves tumor protection by a DNA vaccine in a Her2/neu mouse tumor model. Cancer Gene Therapy. 19(1). 69–76. 28 indexed citations
14.
Weikert, Steffen, Carsten Kempkensteffen, Jonas Busch, et al.. (2011). Sequential mTOR inhibitor treatment with temsirolimus in metastatic renal cell carcinoma following failure of VEGF receptor tyrosine kinase inhibitors. World Journal of Urology. 31(4). 805–809. 15 indexed citations
15.
Andronico, Daniele, et al.. (2010). Semi-automatic procedure for the characterization of the shape of volcanic particles. AGU Fall Meeting Abstracts. 2010. 1 indexed citations
16.
Sturm, Isrid, Joachim Oertel, Stephan Oertel, Jörg Westermann, & Antonio Pezzutto. (2008). Successful long-term monotherapy with rituximab in a patient with chronic lymphocytic leukemia of the B-cell-lineage: a case report. Journal of Medical Case Reports. 2(1). 275–275. 1 indexed citations
17.
Westermann, Jörg, Gerd Baldenhofer, Uta E. Höpken, et al.. (2007). CCL19 (ELC) as an adjuvant for DNA vaccination: induction of a TH1-type T-cell response and enhancement of antitumor immunity. Cancer Gene Therapy. 14(6). 523–532. 30 indexed citations
18.
Westermann, Jörg, Antje van Lessen, Gökben Baskaynak, et al.. (2005). Simultaneous cytokine analysis by cytometric bead array for the detection of leukaemia‐reactive T cells in patients with chronic myeloid leukaemia. British Journal of Haematology. 132(1). 32–35. 6 indexed citations
19.
Daniel, Peter T., Christian Schölz, Frank Eßmann, et al.. (1999). CD95/Fas-triggered apoptosis of activated T lymphocytes is prevented by dendritic cells through a CD58-dependent mechanism. Experimental Hematology. 27(9). 1402–1408. 18 indexed citations
20.
Westermann, Jörg, Alexandra Aicher, & Antonio Pezzutto. (1998). Dendritic Cells for Somatic Gene Therapy. Recent results in cancer research. 144. 70–77.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Il‐Kang Na Breakdown of academic impact, for papers by Janet Ayello Breakdown of academic impact, for papers by Paulo Vidal Campregher Breakdown of academic impact, for papers by Takahiro Shima Breakdown of academic impact, for papers by Mark Klinger Breakdown of academic impact, for papers by HE Heslop Breakdown of academic impact, for papers by Jean‐Jacques Sotto Breakdown of academic impact, for papers by Friederike Kreisel Breakdown of academic impact, for papers by H Mizoguchi Breakdown of academic impact, for papers by Mark W. Brunvand
Rankless by CCL
2026